NADPH-oxidase Inhibitors
| Cat.No. | Product Name | Information | Product Use Citations | Product Validations |
|---|---|---|---|---|
| S5717 | Acetohexamide | Acetohexamide is an intermediate-acting, first-generation oral sulfonylurea with hypoglycaemic activity. It exerts the blood-glucose-lowering effects by stimulating the pancreatic beta cells to secrete insulin and by helping the body use insulin efficiently. | ||
| S4299 | Dicoumarol | Dicoumarol is a competitive NADPH quinone oxidoreductase (NQO1) inhibitor, and used as an anticoagulant by interfering with the Metabolism of vitamin K. |
|
|
| S1907 | Metronidazole | Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is used against protozoa. |
|
|
| S5703 | Carvedilol Phosphate | Carvedilol Phosphate is the phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic sympathomimetic activity. |
|
|
| S9617 | G6PDi-1 | G6PDi-1 is an effective inhibitor of glucose-6-phosphate dehydrogenase (G6PD). This compound depletes NADPH and decreases inflammatory cytokine production. |
|
|
| S6749 | ASP-9521 | ASP-9521 is a selective, orally bioavailable inhibitor of 17beta-hydroxysteroid dehydrogenase type 5 (17β-HSD5), also known as aldo-keto reductase family 1 member C3 (AKR1C3). | ||
| S0764 | AKR1C1-IN-1 | AKR1C1-IN-1 is a potent and selective inhibitor of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) with Ki of 4 nM, 87 nM, 4.2 μM and 18.2 μM for AKR1C1, AKR1C2, AKR1C3 and AKR1C4, respectively. | ||
| S0468New | AKR1C3-IN-1 | AKR1C3-IN-1 is a highly potent inhibitor of aldo-keto reductaseAKR1C3 with an IC50 of 13 nM. It can be used in research targeting both breast and prostate cancer. |
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.